[Form 4] Dynatrace, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Dynatrace director Lisa M. Campbell reported movements of unvested restricted stock units (RSUs). The filing shows 8,099 previously reported unvested RSUs moved from Table I to Table II as derivative securities and a grant of 4,111 RSUs on 08/20/2025. Each RSU converts to one share of common stock when vested. The 4,111 RSUs vest 100% on the earlier of the one-year anniversary (08/20/2026) or the issuer's 2026 annual meeting, subject to continued service. The 8,099 RSUs were originally granted on 09/04/2024 with 25% vesting on 09/04/2025 and the remainder vesting quarterly thereafter.

Insights

Financial Analyst

TL;DR: Routine director equity grant and reclassification; no cash transaction or dilution beyond standard compensation.

The Form 4 documents a non-cash compensation event: movement of 8,099 previously reported time-based RSUs into the derivative securities table and a new grant of 4,111 RSUs that cliff-vest within one year or at the 2026 annual meeting. This is a typical director equity award structure tied to continued service and does not indicate share sales, option exercises, or other liquidity events. Investors should view this as ordinary compensation-related insider reporting rather than a material operational development.

Corporate Governance Expert

TL;DR: Governance-standard director award and reporting; vesting schedule aligns with retention incentives.

The filing shows standard governance practice: time-based RSUs used for director retention with a mix of cliff and quarterly vesting. The reclassification from non-derivative to derivative reporting reflects administrative accuracy rather than a change in economic terms. The award vests conditioned on continued board service, consistent with typical equity-based compensation policies for non-employee directors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Campbell Lisa M

(Last) (First) (Middle)

C/O DYNATRACE, INC.

280 CONGRESS STREET, 11TH FLOOR

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dynatrace, Inc. [ DT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)								0(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)							(4)	(3)	Common Stock	8,099		8,099	D
Restricted Stock Units	(3)	08/20/2025		A		4,111		(5)	(3)	Common Stock	4,111	$0	4,111	D

Explanation of Responses:

1. This Form 4 reports the moving of unvested time-based restricted stock units ("RSUs") previously reported in Table I to Table II in addition to the transactions reflected herein.

2. Reflects a decrease of 8,099 shares of the Issuer's Common Stock representing unvested RSUs that were previously reported in Table I and are being reported in Table II of this Form 4 as derivative securities.

3. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.

4. As previously reported on September 6, 2024, these RSUs were granted on September 4, 2024. 25% of the RSUs granted will vest on September 4, 2025 and the balance of the RSUs vest in equal quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service as director of the Issuer on the applicable vesting dates.

5. Represents the grant of RSUs. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 20, 2026) and the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date.

Remarks:

	/s/ Marc Gold, by power of attorney	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dynatrace director Lisa M. Campbell report on Form 4 (DT)?

She reported movement of 8,099 unvested RSUs from Table I to Table II and a grant of 4,111 RSUs on 08/20/2025.

When do the newly granted 4,111 RSUs vest?

They vest 100% on the earlier of the one-year anniversary (08/20/2026) or the issuer's 2026 Annual Meeting, subject to continued service.

What was the original grant date and vesting schedule for the 8,099 RSUs?

Originally granted 09/04/2024; 25% vests on 09/04/2025 and the balance vests in equal quarterly installments thereafter, subject to continued service.

Did the Form 4 report any cash transactions or share sales by the reporting person?

No cash transactions or share sales were reported; the filing covers RSU reclassification and a new RSU grant.

How many underlying shares does each RSU represent?

Each RSU represents a contingent right to receive one share of Dynatrace common stock upon vesting.